BioSpace News Archive

Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today reported financial results for the three and nine months ended September 30, 2019.

Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., today announced the launch of Ella the Jellyfish, the first Amazon Alexa skill designed for those affected by Lennox-Gastaut Syndrome (LGS).

Creates First Industry Relationship to Pair Earth Observation with Global Communications Infrastructure

The owner of Denver Vein Center, a top vein treatment center in Colorado since 2004, announces a new, integrated approach to patient health care with the launch of EVEXIAS Medical Denver - Colorado’s exclusive provider of EvexiPEL™,

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced financial and operating results for the third quarter ended September 30, 2019.

A new study conducted by the National Kidney Foundation and CareFirst BlueCross BlueShield (CareFirst) found that detecting chronic kidney disease (CKD) with two simple tests and treating it based on severity can improve health outcomes for patients with diabetes and hypertension and lower the cost of caring for them.

Activ Surgical, a pioneering digital intelligence company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility, today announced that Dr. Vipul (Vip) Patel, Medical Director of the Global Robotics Institute at Advent Health Celebration and Medical Director of the Advent Health Cancer Institute Urologic Oncology Program, has joined the company’s Advisory Board.

Dragonfly Therapeutics, Inc. (“Dragonfly”), a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease, today announced that the first patient was dosed in a Phase 1/2 study of DF1001 at The University of Texas MD Anderson Cancer Center in Houston.

Prescient Medicine Holdings, Inc. recently announced Tony Grover as its new Chief Commercial Officer based in Carlsbad, California

The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.